Abstract. species may be detached from these adducts by addition of excess citrate at low pH. The behavior of the investigated ruthenium(Ill) complexes with apoTf is compared with that of the recently described and stdctly related ru-im and ru-ind antitumour complexes, and discussed in the frame of general strategies of drug targeting.
spectroscopy. Interestingly, the hydrolysis profiles of these complexes in a physiological buffer are markedly affected by the presence, in solution, of apoTf suggesting the occurrence of a specific interaction of their respective hydrolysis products with the protein. The formation of stable adducts with apotransferdn has been demonstrated by CD spectroscopy, and additional information obtained through 1H NMR of the hyperfine shifted signals. The bound ruthenium(Ill) species may be detached from these adducts by addition of excess citrate at low pH. The behavior of the investigated ruthenium(Ill) complexes with apoTf is compared with that of the recently described and stdctly related ru-im and ru-ind antitumour complexes, and discussed in the frame of general strategies of drug targeting.
Introduction.
After the discovery of the excellent antitumor properties of cisplatin, in the late seventies, large interest has concentrated on the design and the synthesis of other platinum and nonplatinum metal complexes to be used 
Results
Hydrolysis of I and II within the physiological buffer: the electronic spectra.
Complexes and II are relatively stable under acidic conditions but rapidly hydmlyze at neutral or alkaline pH. Hydrolysis can be easily followed by monitoring the absorption spectra in dependence of time as already reported for complex 17 . Under physiological conditions hydrolysis appears to be at least a two-step process, the first step corresponding to the loss of a first chloride group and the second step to further hydrolytic events. The spectra of and II, recorded at increasing time intervals after mixing with the buffer, at 25C, are shown in Figure 1A and 2A, respectively. The initial spectra are characterized by an intense band at 385 nm plus a shoulder at 445 nm in the case of and by a band at 395 nm plus a shoulder at 465 nm in the case of II. Within few minutes the two main bands and the respective shoulders quickly decrease in intensity and eventually vanish whereas a new intense band appears in both cases around 345 nm. The intensity of the new band reaches a maximum after about half an hour, then, on turn, starts decreasing and vanishes. The final spectrum of in the buffer, recorded several hours later, is characterized by a broad band in the UV with a shoulder around 320 nm. In the case of II, a marked increase in the intensity of the whole spectrum is observed with time; a new, broad band also develops around 570 nm.
Hydrolysis of I and II in the presence ofApoTf-the electronic spectra.
In order to ascertain whether complexes and II interact with apotransferrin we decided to repeat the above hydrolysis experiments within the buffer in the presence of apoTfo The family of spectra obtained upon hydrolysis of and II in the presence of the protein are respectively shown in Figure 1B and 2B.
The first part of the hydrolysis of both complexes within the buffer as monitored through absorption spectroscopy is not significantly affected by apoTf even if the hydrolysis rates are significantly enhanced. During the second phase of the hydrolysis, however, the absorption spectra, differ significantly from those obtained in the absence of apoTf. The final spectra are invariably characterized by a broad, relatively intense transition in the visible, located around 500 Hydrolysis of II in the buffer in the absence (A) and in the presence (B) of apoTf as followed through absorption spectroscopy. Traces a, b, c and d in Figure A were respectively recorded 3, 30 and 120 and 240 minutes after mixing. Trace e is the spectrum recorded the day after. Traces a, b, c in Figure B were recorded at 3, 10 and 30 minutes after mixing. Trace d was recorded the day after.Conditions: [11] To better elucidate the formation of specific adducts between complexes and II and apoTf we analyzed the final hydrolysis products obtained both in the absence and in the presence of apoTf, by CD spectroscopy. CD spectroscopy is a valuable tool to demonstrate the specific binding of small metal complexes, with transitions in the visible region, to chiral biomolecules19. Whereas, as expected, no CD band was observed in the case of the complexes dissolved in the buffer, the spectra of the samples dissolved in buffered apoTf solutions, at a 2:1 ratio, showed characteristic CD transitions in the visible region (Figure 3 ). More in detail, the spectrum of plus apoTf consists of two positive transitions at 370 and 480 nm; that of II plus apoTf shows two positive transitions at 375 and 495 nm. The detection of these CD transitions provides unambiguous evidence for a tight interaction between the ruthenium(Ill) chromophore and the chiral macromolecule in both cases. Interestingly the CD spectra develop a few hours after mixing in concomitance with the second hydrolytic process of both complexes. CD spectra in the visible region of plus-apoTf (A) and II plus-apoTf (B). At 25 C both spectra fully develop about 60-90 minutes after mixing. The samples of Figures 1B and 2B were used.
The CD spectra differ markedly from those, previously reported, of ruthenium(Ill) transferrin 20 ruling out that the bound species is the bare ruthenium(Ill) ion. Moreover, the fact that the CD spectra of plus apoTf and II-plus apoTf, although similar, are different in shape and intensity suggests that in the protein-bound species the heterocycle remains attached to the ruthenium(Ill) Figure 4A and 4B. The assignment of the 1H NMR spectrum of has been previously reported17. The spectrum of II is poorer and yet not assigned ( Figure 4A and B) ; it is straightfonNard, however, to attribute the intense (and virtually only) feature observed at-14 ppm to the methyl groups of the ruthenium(lll)-bound DMSO moiety. 1H NMR spectra of (a) and II (b) freshly dissolved in D20. spectra are shown in Figure 6 . Upon addition of two equivalents of II to a solution containing l mM apoTf an intense, broad hyperfine signal at-15 ppm is observed; within few hours the spectrum transforms into another spectrum characterized by an intense sharper resonance at -14 ppm. This spectrum is markedly different from that of plus-apoTf, implying a somewhat unequivalent structure for the two adducts.
Discussion.
Targeting of antitumor complexes.
The concept of drug targeting may be of great help when dealing with drugs characterized by a narrow therapeutic index. The main goal of drug targeting strategies is to obtain a more favorable biodistdbution of a drug within the organism, thus reducing its systemic toxicity. Even if the selectivity of transferdn conjugates owing to the large distribution of the transferdn receptors in the organism 9-may not be as high as that of monoclonal antibodies conjugates, transferrin conjugates show a number of properties that make them suitable for drug targeting experiments. Indeed, by using transferdn as carder, it is possible, in principle, to achieve a preferential uptake of the drug by those tissues that exhibit a large demand of iron, in other words by fast replicating tissues like cancer tissues. Previous reports on the use of transferrin as a carder of cytostatic drugs or toxins are in the literature12-15. We have attempted to apply this strategy to a series of ruthenium(Ill) complexes with a structure resemblant that of cisplatin.
Binding of and II to apoTf.
The preliminary-and indispensable-step of this kind of studies is represented by the preparation and characterization of stable adducts between the metal complexes and transferrin and by the assessment of their acid lability16. We have reported here on the interaction of and II with apotransferrin under physiological conditions, as monitored by spectroscopic methods. The absorption spectroscopy studies allowed us to describe in detail the hydrolysis processes that occur when the two ruthenium(Ill) complexes are exposed to a neutral environment. In the absence of transferrin, both complexes roughly follow the same hydrolysis pathway comprising a "fast phase" that reaches completion within about half an hour and a "slow phase" that takes hours. When repeating the same reaction in the presence of apoTf significant variations are observed dudng the "slow phase", ascdbed to a direct interaction of the hydrolysis products of both complexes with the protein. 
